HJF Medical Research International reposted this
Watch now! IAVI's Dr. Gaudensia Mutua and HJF Medical Research International's Dr. Abdulwasiu Bolaji Tiamiyu were recently interviewed by NTAi News about IAVI C105, the first #LassaFever vaccine candidate to enter a Phase 2 clinical trial. They discussed African scientists' and communities' leading roles in developing this vaccine – plus, how these efforts drive forward global health progress. ▶ https://lnkd.in/ey23GxM3 CEPI (Coalition for Epidemic Preparedness Innovations)
Clinical Trials' Manager at UVRI-IAVI HIV Vaccine Program
3moThank you dear Drs for the great work. You made us proud.